European Commission grants orphan drug designation to sirolimus for sickle cell disease Jan. 25, 2018 No Comments
Imara initiates proof-of-concept phase II study of IMR-687 in sickle cell anemia Jan. 23, 2018 No Comments
New phase III trial explores use of BAX-111 in pediatric severe hereditary von Willebrand disease Jan. 22, 2018 No Comments
RSS